A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Seagen Inc.
Eli Lilly and Company
Tomsk National Research Medical Center of the Russian Academy of Sciences
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Boehringer Ingelheim
ViroMissile, Inc.
Erasca, Inc.
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Poseida Therapeutics, Inc.
MacroGenics
Revolution Medicines, Inc.
Pheon Therapeutics
City of Hope Medical Center
SN BioScience
Eli Lilly and Company
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Pfizer
Bristol-Myers Squibb
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
University of Southern California
AbbVie
Actym Therapeutics, Inc.
HUYABIO International, LLC.
HUYABIO International, LLC.
Ikena Oncology
Memgen, Inc.
Revolution Medicines, Inc.
GONGCHU Biotechnology Co., Ltd
Day One Biopharmaceuticals, Inc.
Jonsson Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
Trishula Therapeutics, Inc.
Novita Pharmaceuticals, Inc.
Trishula Therapeutics, Inc.
NextPoint Therapeutics, Inc.
Nuvation Bio Inc.
DEKA Biosciences
Monopar Therapeutics
Monopar Therapeutics
Columbia University
Hummingbird Bioscience
Mirati Therapeutics Inc.
Exelixis
Shanghai JMT-Bio Inc.
National Cancer Institute (NCI)